ECOR
$6.83+0.55 (+8.66%)
electroCore, Inc., a bioelectronic medicine and general wellness company, provides non-invasive vagus nerve stimulation (nVNS) technology platform in the United States, the United Kingdom, and internationally.
Recent News
Analysts Estimate Nektar Therapeutics (NKTR) to Report a Decline in Earnings: What to Look Out for
Nektar (NKTR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
OmniAb, Inc. (OABI) Reports Q4 Loss, Misses Revenue Estimates
OmniAb, Inc. (OABI) delivered earnings and revenue surprises of -33.33% and -5.14%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
electroCore, Inc. (ECOR) May Report Negative Earnings: Know the Trend Ahead of Q4 Release
electroCore (ECOR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Amneal Pharmaceuticals (AMRX) Q4 Earnings Top Estimates
Amneal (AMRX) delivered earnings and revenue surprises of +18.85% and -0.19%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Analysts Expect Breakeven For electroCore, Inc. (NASDAQ:ECOR) Before Long
We feel now is a pretty good time to analyse electroCore, Inc.'s ( NASDAQ:ECOR ) business as it appears the company may...